NO976030D0 - Fremgangsmåte for optisk rensing av enantiomerisk anrikede benzimidazolderivater - Google Patents

Fremgangsmåte for optisk rensing av enantiomerisk anrikede benzimidazolderivater

Info

Publication number
NO976030D0
NO976030D0 NO976030A NO976030A NO976030D0 NO 976030 D0 NO976030 D0 NO 976030D0 NO 976030 A NO976030 A NO 976030A NO 976030 A NO976030 A NO 976030A NO 976030 D0 NO976030 D0 NO 976030D0
Authority
NO
Norway
Prior art keywords
enantiomerically enriched
benzimidazole derivatives
optical purification
enriched benzimidazole
purification
Prior art date
Application number
NO976030A
Other languages
English (en)
Other versions
NO976030L (no
NO313008B1 (no
Inventor
Sverker Von Unge
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20397468&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO976030(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO976030D0 publication Critical patent/NO976030D0/no
Publication of NO976030L publication Critical patent/NO976030L/no
Publication of NO313008B1 publication Critical patent/NO313008B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
NO19976030A 1995-07-03 1997-12-22 Fremgangsmåte for optisk rensing av enantiomerisk anrikede benzimidazolderivater NO313008B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49193995A 1995-07-03 1995-07-03
SE9500817 1995-07-03
PCT/SE1996/000841 WO1997002261A1 (en) 1995-07-03 1996-06-26 A process for the optical purification of enantiomerically enriched benzimidazole derivatives

Publications (3)

Publication Number Publication Date
NO976030D0 true NO976030D0 (no) 1997-12-22
NO976030L NO976030L (no) 1998-02-09
NO313008B1 NO313008B1 (no) 2002-07-29

Family

ID=20397468

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19976030A NO313008B1 (no) 1995-07-03 1997-12-22 Fremgangsmåte for optisk rensing av enantiomerisk anrikede benzimidazolderivater

Country Status (37)

Country Link
US (1) US5929244A (no)
EP (2) EP0836601B1 (no)
JP (1) JP4195507B2 (no)
KR (1) KR100451078B1 (no)
CN (1) CN1098261C (no)
AT (1) ATE418549T1 (no)
AU (1) AU698638B2 (no)
BR (1) BR9609450A (no)
CA (1) CA2226184C (no)
CZ (1) CZ295430B6 (no)
DE (1) DE69637788D1 (no)
DK (1) DK0836601T3 (no)
DZ (1) DZ2057A1 (no)
EE (1) EE03444B1 (no)
ES (1) ES2318850T3 (no)
HK (1) HK1010193A1 (no)
HR (1) HRP960232A2 (no)
HU (1) HUP9901717A3 (no)
IL (1) IL122811A (no)
IS (1) IS2666B (no)
MA (1) MA23921A1 (no)
MY (1) MY114018A (no)
NO (1) NO313008B1 (no)
NZ (1) NZ311842A (no)
PL (1) PL186702B1 (no)
PT (1) PT836601E (no)
RS (1) RS49826B (no)
RU (1) RU2144031C1 (no)
SA (1) SA96170103B1 (no)
SI (1) SI0836601T1 (no)
SK (1) SK284780B6 (no)
TN (1) TNSN96090A1 (no)
TR (1) TR199701754T1 (no)
TW (1) TW444010B (no)
UA (1) UA49838C2 (no)
WO (1) WO1997002261A1 (no)
ZA (1) ZA965205B (no)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP960232A2 (en) * 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
WO1998054172A1 (en) * 1997-05-30 1998-12-03 Dr. Reddy's Research Foundation Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
AU742620B2 (en) * 1998-01-30 2002-01-10 Sepracor, Inc. R-lansoprazole compositions and methods
SE9900274D0 (sv) 1999-01-28 1999-01-28 Astra Ab New compound
TWI289557B (en) 1999-06-17 2007-11-11 Takeda Chemical Industries Ltd A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
ES2240113T3 (es) 1999-06-30 2005-10-16 Takeda Pharmaceutical Company Limited Cristales de lansoprazol.
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
EP1897877B1 (en) 2000-05-15 2014-09-24 Takeda Pharmaceutical Company Limited Crystalline forms of (R)-lanzoprazole
EP1306375B1 (en) 2000-08-04 2006-10-11 Takeda Pharmaceutical Company Limited Salts of benzimidazole compound and application thereof
PL399787A1 (pl) * 2000-12-01 2012-11-05 Takeda Pharmaceutical Company Ltd. Krysztaly (R)- lub (S)-2-[[[3-metylo-4-(2,2,2-trifluoroetoksy)-2-pirydynylo]metylo]sulfinylo]-1H-benzimidazolu, kompozycja farmaceutyczna zawierajaca te krysztaly i ich zastosowanie
KR100433735B1 (ko) * 2001-06-27 2004-06-04 주식회사 씨트리 결정형 ⅰ을 갖는 란소프라졸의 제조방법
SE0104295D0 (sv) * 2001-12-18 2001-12-18 Astrazeneca Ab New process
US20040006111A1 (en) * 2002-01-25 2004-01-08 Kenneth Widder Transmucosal delivery of proton pump inhibitors
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
CA2502219C (en) 2002-10-16 2012-05-29 Takeda Pharmaceutical Company Limited A process for producing an amorphous isomer of lansoprazole
DE10254167A1 (de) 2002-11-20 2004-06-09 Icon Genetics Ag Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen
MXPA05005762A (es) 2002-12-06 2005-08-16 Altana Pharma Ag Procedimiento para preparar compuestos activos opticamente puros.
ES2383679T3 (es) 2002-12-06 2012-06-25 Nycomed Gmbh Procedimiento para la preparación de (S)-pantoprazol
JP2006518751A (ja) * 2003-02-20 2006-08-17 サンタラス インコーポレイティッド 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物
US20060247277A1 (en) * 2003-02-28 2006-11-02 Yatendra Kumar Polymorphs of s-omeprazole
MXPA06000524A (es) * 2003-07-18 2006-08-11 Santarus Inc Formulacion farmaceutica y metodo para tratar desordenes gastrointestinales provocados por acido.
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US7005732B2 (en) * 2003-10-21 2006-02-28 Honeywell International Inc. Methods and systems for providing MEMS devices with a top cap and upper sense plate
FR2863609A1 (fr) * 2003-12-15 2005-06-17 Isochem Sa Procede d'enrichissement enantiomerique d'un melange d'enantiomeres d'alpha-aminoacides
SE0400410D0 (sv) * 2004-02-20 2004-02-20 Astrazeneca Ab New compounds
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8461187B2 (en) 2004-06-16 2013-06-11 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
US7553857B2 (en) 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
US7786309B2 (en) * 2006-06-09 2010-08-31 Apotex Pharmachem Inc. Process for the preparation of esomeprazole and salts thereof
FR2909380B1 (fr) * 2006-12-04 2009-02-20 Sidem Pharma Sa Sa Conglomerats de sels de potassium de tenatoprazole
EP1947099A1 (en) 2007-01-18 2008-07-23 LEK Pharmaceuticals D.D. Process for solvent removal from omeprazole salts
CN101323609B (zh) * 2007-06-15 2013-05-01 成都福瑞生物工程有限公司 不对称氧化硫醚成亚砜合成对映体含量高的苯并咪唑衍生物的方法
BRPI0813191B1 (pt) * 2007-06-15 2021-09-08 Emcure Pharmaceuticals Limited Processo de sulfoxidação de compostos biologicamente ativos
FR2920428B1 (fr) * 2007-08-29 2012-06-15 Univ Rouen Procede de dedoublement de sels de l'omeprazole
UA103189C2 (ru) 2008-03-10 2013-09-25 Такеда Фармасьютикал Компани Лимитед Кристаллическая форма бензимидазольного соединения
WO2010058409A2 (en) 2008-11-18 2010-05-27 Hetero Research Foundation Optical purification of esomeprazole
KR101001646B1 (ko) * 2008-12-12 2010-12-17 한미약품 주식회사 (ｒ)-(+)-란소프라졸의 제조방법 및 이에 사용되는 중간체
WO2011004387A2 (en) 2009-06-18 2011-01-13 Matrix Laboratories Ltd Process for the preparation of dexlansoprazole polymorphic forms
EP2499125B1 (en) 2009-11-12 2016-01-27 Hetero Research Foundation Process for the resolution of omeprazole
WO2011092665A1 (en) 2010-01-29 2011-08-04 Ranbaxy Laboratories Limited Process for the preparation of crystalline forms of dexlansoprazole
CA2956699C (en) 2014-07-30 2020-09-29 Aetas Pharma Co., Ltd. Optical isomer of 1,4-benzothiazepine-1-oxide derivative, and pharmaceutical composition prepared using same
EP3064495B1 (en) 2015-03-06 2016-12-14 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of optically pure esomeprazole

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) * 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
EP0434999B1 (en) * 1989-11-29 1994-08-17 Toa Eiyo Ltd. Cycloheptenopyridine derivatives, process for preparation thereof and antiulcer agents containing the same
DE4035455A1 (de) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
IS4232A (is) * 1993-12-06 1995-06-07 Astra Aktiebolag Súbstitúerað bensimidasól, aðferðir við framleiðslu þess og lyfjafræðileg notkun
HRP960232A2 (en) * 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds

Also Published As

Publication number Publication date
IL122811A0 (en) 1998-08-16
HK1010193A1 (en) 1999-06-17
UA49838C2 (uk) 2002-10-15
MY114018A (en) 2002-07-31
EP1498416A1 (en) 2005-01-19
DZ2057A1 (fr) 2002-10-20
CZ295430B6 (cs) 2005-08-17
KR100451078B1 (ko) 2004-11-16
RU2144031C1 (ru) 2000-01-10
EP0836601A1 (en) 1998-04-22
TW444010B (en) 2001-07-01
AU698638B2 (en) 1998-11-05
IS2666B (is) 2010-08-15
CZ421197A3 (cs) 1998-06-17
US5929244A (en) 1999-07-27
DK0836601T3 (da) 2009-03-16
NO976030L (no) 1998-02-09
SK284780B6 (sk) 2005-11-03
NZ311842A (en) 1998-12-23
RS49826B (sr) 2008-08-07
NO313008B1 (no) 2002-07-29
HRP960232A2 (en) 1998-02-28
EP0836601B1 (en) 2008-12-24
SI0836601T1 (sl) 2009-04-30
BR9609450A (pt) 1999-03-02
CN1193971A (zh) 1998-09-23
IL122811A (en) 2000-11-21
PT836601E (pt) 2009-02-17
MX9800160A (es) 1998-03-31
ATE418549T1 (de) 2009-01-15
YU37696A (sh) 1999-03-04
HUP9901717A2 (hu) 2000-04-28
EE9700368A (et) 1998-06-15
TNSN96090A1 (fr) 2005-03-15
CA2226184A1 (en) 1997-01-23
PL324394A1 (en) 1998-05-25
JPH11508590A (ja) 1999-07-27
SA96170103B1 (ar) 2006-07-30
TR199701754T1 (xx) 1998-04-21
WO1997002261A1 (en) 1997-01-23
AU6324096A (en) 1997-02-05
HUP9901717A3 (en) 2002-03-28
CN1098261C (zh) 2003-01-08
ZA965205B (en) 1997-01-03
EE03444B1 (et) 2001-06-15
KR19990028631A (ko) 1999-04-15
DE69637788D1 (de) 2009-02-05
CA2226184C (en) 2008-08-05
SK179397A3 (en) 1998-09-09
JP4195507B2 (ja) 2008-12-10
MA23921A1 (fr) 1996-12-31
IS4638A (is) 1997-12-22
PL186702B1 (pl) 2004-02-27
ES2318850T3 (es) 2009-05-01

Similar Documents

Publication Publication Date Title
NO976030L (no) Fremgangsmåte for optisk rensing av enantiomerisk anrikede benzimidazolderivater
DE69632249D1 (de) Herstellung optischer elemente
NO306943B1 (no) Fremgangsmåte for fremstilling av enantiomerene av O- demetyltramadol
DE69423179T2 (de) Prozess zur Herstellung von optisch aktiven 2-Amino-1-phenylethanol Derivaten
NO971567D0 (no) Fremgangsmåte for rensing av keratinocyttvekstfaktorer
DE69605202T2 (de) Herstellung von alpha-tocopherol
NO976056L (no) Fremgangsmåte for fremstilling av enantiomerisk ren azetidin-2-karboksylsyre
NO990450D0 (no) Behandling av sinnslidelser
NO974524D0 (no) Fremgangsmåte for rensing av glykoproteiner som erytropoietin
DE69603003T2 (de) Suspensionsverfahren zur Herstellung von Acrylpolymeren
DE69603419T2 (de) Verfahren zur Herstellung von optisch aktiven Amiden
DE69623986D1 (de) Herstellung von Allomelanin
DE69409733D1 (de) Verfahren zur Herstellung optisch aktiven 2-Norbornanons
NO973895D0 (no) Anlegg for fremstilling av hydrogenperoksyd
FI950787A0 (fi) Arrangemang foer optisk fjaerrstyrning av en anordning
NO942651D0 (no) Fremgangsmåte for bleking av papirmasse
FI955879A (fi) Menetelmä kraft-massan valkaisemiseksi

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees